Kathleen S. Capps's most recent trade in Enanta Pharmaceuticals Inc was a trade of 323 Common Stock done at an average price of $14.2 . Disclosure was reported to the exchange on Dec. 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Enanta Pharma Inc | Kathleen S. Capps | See Remarks | Sale of securities on an exchange or to another person at price $ 14.23 per share. | 05 Dec 2025 | 323 | 8,377 (0%) | 0% | 14.2 | 4,596 | Common Stock |
| Enanta Pharma Inc | Kathleen S. Capps | See Remarks | Sale of securities on an exchange or to another person at price $ 13.96 per share. | 01 Dec 2025 | 207 | 8,700 (0%) | 0% | 14.0 | 2,890 | Common Stock |
| Enanta Pharma Inc | Kathleen S. Capps | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.12 per share. | 01 Dec 2025 | 85 | 8,907 (0%) | 0% | 14.1 | 1,200 | Common Stock |
| Enanta Pharma Inc | Kathleen S. Capps | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2025 | 6,325 | 6,325 | - | - | Stock Option (right to buy) | |
| Enanta Pharma Inc | Kathleen S. Capps | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2025 | 3,163 | 8,992 (0%) | 0% | 0 | Common Stock |